Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_assertion type Assertion NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_head.
- NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_assertion wasGeneratedBy ECO_0000203 NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_provenance.
- NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_assertion wasDerivedFrom befree-2016 NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_provenance.
- NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_assertion SIO_000772 23406679 NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_provenance.
- NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_assertion evidence source_evidence_literature NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_provenance.
- NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_assertion description "[In primary samples, MIR129-2 methylation was absent in AML and CML, but detected in 5% ALL, 45.9% CLL, 49.5% MM at diagnosis, and 59.1% NHL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_provenance.